Edition:
United States

OPKO Health Inc (OPK.OQ)

OPK.OQ on NASDAQ Stock Exchange Global Select Market

4.94USD
17 Nov 2017
Change (% chg)

$0.07 (+1.44%)
Prev Close
$4.87
Open
$4.83
Day's High
$5.01
Day's Low
$4.80
Volume
1,020,668
Avg. Vol
994,575
52-wk High
$12.15
52-wk Low
$4.50

Chart for

About

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in... (more)

Overall

Beta: 1.97
Market Cap(Mil.): $2,763.46
Shares Outstanding(Mil.): 559.41
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.35 15.79
EPS (TTM): -- -- --
ROI: -- 15.11 12.01
ROE: -- 16.52 15.91

BRIEF-Opko Health qtrly loss per share $0.08‍​

* Opko Health reports 2017 third quarter highlights and financial results

Nov 08 2017

BRIEF-OPKO Health submits premarket approval application with FDA for PSA test

* OPKO Health submits premarket approval application with FDA for a point-of-care PSA test with the Claros 1 platform

Nov 07 2017

BRIEF-Opko Health licensee Tesaro announces FDA approval of Varubi IV for delayed nausea, vomiting associated with chemotherapy

* Opko Health licensee Tesaro announces FDA approval of Varubi IV for delayed nausea and vomiting associated with chemotherapy

Oct 26 2017

BRIEF-Opko Health enters into exclusive agreement with Japan Tobacco to develop and commercialize Rayaldee in Japan

* Opko Health enters into exclusive agreement with Japan Tobacco to develop and commercialize Rayaldee® in Japan

Oct 12 2017

Earnings vs. Estimates